A drug already used safely to treat Parkinson’s disease and other movement disorders also could delay or prevent the most common cause of blindness in older adults, affecting more than 9 million Americans, according to researchers.
A test leading to the diagnosis of Alzheimer’s disease 10 to 30 years before symptoms appear has been formally classified as the international reference method, which means that it will be used as the standard in Alzheimer’s diagnostics worldwide.
A $3.4 million, five-year, seven-state study will examine the off-label use of antipsychotic medications in residents with dementia living in assisted living communities.
Life plan community is the new name for continuing care retirement community that has arisen from the CCRC Namestorm initiated by LeadingAge and Mather LifeWays. The name was announced at the opening general session of LeadingAge’s annual meeting Sunday.
Occupancy rates for independent and assisted living appear to be peaking, according to one analyst.